Trichoderma as a biological elicitor of medicinal plant bioactive compounds: mechanisms, pharmaceutical significance and translational challenges
Archives of Pharmacy and Pharmaceutical Sciences · 13.11.2026 · 21-40
DOI: 10.29328/journal.apps.1001072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Pharmacy and Pharmaceutical Sciences, online erschienen am 13.11.2026. Verfasst von Suyun Li und 2 weiteren Autor:innen. Die Arbeit nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Medicinal plants remain the principal industrial source of many pharmacologically indispensable molecules, yet the supply of these compounds is constrained by slow growth cycles, low and variable accumulation, and the ecological pressure exerted by wild harvesting. Interventions that raise the content of active constituents in cultivated material without reducing biomass are therefore of direct pharmaceutical interest. Species of the fungal genus Trichoderma occupy a distinctive position in this context: they are simultaneously rhizosphere-competent symbionts, mycoparasites deployed as registered biological control agents, and prolific producers of small-molecule and proteinaceous effectors. Root colonization is perceived by the host as a microbial encounter and triggers a transient, self-limiting immune response followed by a state of primed defence, in which jasmonate, salicylate, ethylene and oxylipin signalling are rewired and redox homeostasis is re-set. The proposed mechanistic framework links root perception and transient calcium/ROS/MAPK responses to context-dependent salicylate–jasmonate–ethylene crosstalk, systemic oxylipin signalling, redox regulation and chromatin-associated priming. These inputs converge on transcriptional regulators and precursor supply to influence phenylpropanoid and terpenoid biosynthesis and, depending on host context, other specialised metabolic pathways. However, pathway activation cannot be assumed to yield a higher concentration of a particular pharmaceutical marker. The 27 study records in Table 1 are therefore distinguished by treatment type and strength of attribution: five single-organism applications to living plants, one fermentation and one post-harvest enzymatic conversion, six combinations explicitly including Trichoderma, thirteen systems without Trichoderma, and one purified microbial metabolite applied to plant material. The most secure Trichoderma-specific results concern a dose-dependent cannabidiol increase in hemp, four rhizome marker compounds of Atractylodes lancea (three sesquiterpenoids and the polyacetylene atractylodin), grape anthocyanins and grain phenolics and anthocyanins in rice; for ginsenosides, artemisinin and medicinal storage polysaccharides, in planta evidence remains absent or indirect, and the single Trichoderma record for tanshinones reports a significant increase without a numerical effect size. Secreted elicitors, including cerato-platanin proteins, cellulases, peptaibols, polyketides such as harzianic acid and sorbicillinoids, and the volatile 6-pentyl-2H-pyran-2-one, have been associated with plant signalling or other biological activities, motivating the evaluation of defined elicitation protocols. This review synthesises the molecular dialogue between Trichoderma and medicinal plants, summarised as a working model in Figure 1, evaluates the evidence for metabolite-level outcomes by chemical class and by attribution (Table 1), and examines the pharmaceutical, safety and regulatory questions integrated in Figure 2 that determine whether the interaction can be converted into a quality-by-design strategy for herbal raw materials.
Zitieren
APA
Li, S., Mao, Q., & Fang, T. (2026). Trichoderma as a biological elicitor of medicinal plant bioactive compounds: mechanisms, pharmaceutical significance and translational challenges. Archives of Pharmacy and Pharmaceutical Sciences, 21-40. https://doi.org/10.29328/journal.apps.1001072
Vancouver
Li S, Mao Q, Fang T. Trichoderma as a biological elicitor of medicinal plant bioactive compounds: mechanisms, pharmaceutical significance and translational challenges. Archives of Pharmacy and Pharmaceutical Sciences. 2026:21-40. doi:10.29328/journal.apps.1001072
BibTeX
@article{Li2026,
author = {Li, Suyun and Mao, Qiancheng and Fang, Tianhe},
title = {Trichoderma as a biological elicitor of medicinal plant bioactive compounds: mechanisms, pharmaceutical significance and translational challenges},
journal = {Archives of Pharmacy and Pharmaceutical Sciences},
year = {2026},
pages = {21--40},
doi = {10.29328/journal.apps.1001072}
}
EUVIMED